Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

Benzer Materyaller

• Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine
  Yazar:: Huang, Claire Y.-H., ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Attenuation Markers of a Candidate Dengue Type 2 Vaccine Virus, Strain 16681 (PDK-53), Are Defined by Mutations in the 5′ Noncoding Region and Nonstructural Proteins 1 and 3
  Yazar:: Butrapet, Siritorn, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
  Yazar:: Osorio, Jorge E., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus
  Yazar:: Huang, Claire Y.-H., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
  Yazar:: Guirakhoo, F., ve diğerleri
  Baskı/Yayın Bilgisi: (2004)